Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report)’s share price traded up 0.1% during mid-day trading on Thursday . The stock traded as high as $0.3208 and last traded at $0.3208. Approximately 292 shares were traded during mid-day trading, a decline of 97% from the average session volume of 9,624 shares. The stock had previously closed at $0.3206.
Algernon Pharmaceuticals Stock Performance
The business’s 50-day moving average is $0.31 and its 200-day moving average is $0.14.
Algernon Pharmaceuticals Company Profile
Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.
The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).
Further Reading
- Five stocks we like better than Algernon Pharmaceuticals
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
